Artiva Biotherapeutics (ARTV) Total Current Liabilities (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Total Current Liabilities of $10.9 million for Q1 2026, down 10.85% year-over-year from $12.2 million in Q1 2025, and down 16.86% quarter-over-quarter from $13.1 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Total Current Liabilities (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Total Current Liabilities for 4 consecutive years, with $10.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 10.85% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $10.9 million (down 10.85% YoY), while the FY2025 annual figure was $13.1 million, up 6.81% from the prior year.
- Total Current Liabilities eased to $10.9 million in Q1 2026 per ARTV's latest filing, from $13.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $13.3 million in Q3 2024 and bottomed at $10.8 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $11.9 million across 4 years, with a median of $12.2 million in 2025.
- On a YoY basis, Total Current Liabilities climbed as much as 6.81% in 2025 and fell as far as 16.35% in 2025.
- Artiva Biotherapeutics' Total Current Liabilities stood at $12.2 million in 2023, then increased by 0.21% to $12.3 million in 2024, then gained by 6.81% to $13.1 million in 2025, then slipped by 16.86% to $10.9 million in 2026.
- Business Quant data shows ARTV's Total Current Liabilities at $10.9 million in Q1 2026, $13.1 million in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 14.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.58 Mn |
| Mar 31, 2026 | 10.88 Mn |
| Dec 31, 2025 | 13.09 Mn |
| Sep 30, 2025 | 11.12 Mn |
| Jun 30, 2025 | 10.77 Mn |
| Mar 31, 2025 | 12.20 Mn |
| Dec 31, 2024 | 12.25 Mn |
| Sep 30, 2024 | 13.29 Mn |
| Jun 30, 2024 | 10.83 Mn |
| Dec 31, 2023 | 12.23 Mn |